Neostigmine for non-mild acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials

Neostigmine for non-mild acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials

Background: The therapeutic value of neostigmine as a prokinetic drug in acute pancreatitis (AP), especially in non-mild AP, including moderately severe and severe AP remains controversial. This meta-analysis aimed to investigate the efficacy of neostigmine treatment in patients with non-mild AP.Met...

Full description

Bibliographic Details
Main Authors: Kun He, Yabing Wang, Jianing Li, Xiaoyin Bai, Zihan Yang, Xianlin Han, Dong Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pharmacology
Subjects:
acute pancreatitis
neostigmine
prokinetic drug
gastrointestinal motility
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1131974/full

Similar Items

Similar Items